SM
NVAX icon

Skaana Management’s Novavax NVAX Stock Holding History

Skaana Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,300
Closed -$459K – 158
2025
Q4 		$459K Buy
+68,300
New +$515K 0.15% 77
2025
Q3 		– Sell
-146,206
Closed -$1.14M – 158
2025
Q2 		$921K Sell
146,206
-5,000
-3% -$33.1K 0.28% 56
2025
Q1 		$969K Sell
151,206
-183,681
-55% -$1.52M 0.35% 47
2024
Q4 		$2.69M Buy
334,887
+1,000
+0.3% +$9.64K 0.69% 32
2024
Q3 		$4.22M Buy
333,887
+97,293
+41% +$1.26M 1.02% 20
2024
Q2 		$3M Buy
236,594
+173,467
+275% +$1.75M 0.92% 29
2024
Q1 		$302K Buy
+63,127
New +$293K 0.01% 107
2023
Q4 		– Sell
-86,366
Closed -$529K – 202
2023
Q3 		$625K Sell
86,366
-65,569
-43% -$524K 0.15% 77
2023
Q2 		$1.13M Buy
+151,935
New +$1.19M 0.25% 65

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Skaana Management's NVAX Position: Q1 2026 in Review

Skaana Management sold out of Novavax (NVAX) in Q1 2026, closing a stake of 68,300 shares — an estimated $459K sold.

Skaana Management first reported a position in NVAX in Q2 2023 and held it in 9 quarters. The position peaked at $4.22M in Q3 2024. 259 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Skaana Management reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • Skaana Management sold 68,300 Novavax shares in Q1 2026, an estimated $459K.
  • Skaana Management first reported a position in Novavax in Q2 2023 and held it in 9 quarters.
  • Skaana Management's Novavax position peaked at $4.22M in Q3 2024.
  • 259 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Skaana Management's 13F filing for Q1 2026, filed 11 May 2026.